The U.S. Federal Trade Commission (FTC) has slammed pharmacy benefit managers (PBMs) owned by UnitedHealth ($UNH), CVS Health ...
The new document focuses on the influence of PBMs over the market for specialty generic drugs for illnesses like cancer, ...
The FDC released a second highly critical report of PBMs, which may provide further impetus for legislative action to curb ...
CVS Caremark Rx blasted the findings for cherry picking certain drugs in an effort to push what it called an 'anti-PBM' ...
Agency commissioners voted unanimously on Tuesday to publish the report, which makes similar allegations against the ...
In the debate over the high cost of prescription drugs, pharmacy benefit managers are hotly contested. PBMs, the middlemen in ...
From 2017 to 2022, the companies marked up prices at their pharmacies by hundreds or thousands of percent, netting them $7.3 ...
An Alabama lawmaker believes prescription care management should be a legislative priority during the upcoming session.
FOX 9 Minneapolis-St. Paul on MSN20h
FTC says Optum, other prescription benefit managers inflate cancer drug prices 1,000%Prescription benefit managers have been under growing scrutiny from state and federal regulators who have accused them of creating pharmacy deserts by steering consumers to their own pharmacies and ...
The new lawsuit cites the fine as an example of how the Commerce Department has been “aggressively enforcing” the state’s PBM law. Following the consent order with CVS Caremark, the ...
An Alabama lawmaker believes prescription care management should be a legislative priority during the upcoming session.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback